The association of decreased circadian clock gene expression was also observed in different molecular subtypes of breast cancer (Desmedt et al., 2007[4]; Schmidt et al., 2008[13][14], 2009[16]) and was independent of established clinical factors. The gene discussed is CLOCK; the disease is breast cancer.